CD40LG and liver cancer: As for SCCA-IgM isoforms and liver cancer, our findings clearly document a graduate decrease of serpinB4-IgM/serpinB3-IgM ratio when comparing patients with different extent of liver disease, despite not reaching statistically significant differences due to the limited number of the patients included in the study.